[S2] シンポジウム2 小児神経領域におけるアンチセンス核酸とin vivo遺伝子治療の今までの展開と今後の課題

[S2-3] Current status of in vivo gene therapy for Duchenne muscular dystrophy

^○Hirofumi Komaki (Translational Medical Center, National Center of Neurology and Psychiatry)

Password required to view